Ledger.Open graph →
SEC Form D · filed June 22, 2020

Adaptive Phage Therapeutics, Inc

Offering
$7.0M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Gregory L. Merril · Gaithersburg, MDExec · DirectorMaren Steinberg · DENVER, COExec · DirectorGuillermo Guefen · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗